CompanyGraph
At a glance
- Depends onMidstream position: 6 outgoing, 6 incoming connections
- ScaleMarket cap is $3.12B, above the global median of $1.15B
- PositionGross margin is -35.1%, lower than 95% of its Diagnostics & Research peers (median 47%)
- Interpretations2 currently firing — 2
Sign in to view price data.
Sign inThe reported statements, read against the company's own industry.
Financials view
Market Capitalization
3.12BUSDvs all stocks (USD)
Revenue (TTM)
156.12MUSDvs all stocks (USD)
Profit Margin
-253.22%vs Diagnostics & Research peers
Beta
3.22xvs all stocks
52-Week Change
111.41%vs all stocks
Market Capitalization
3.12BUSDvs all stocks (USD)
Enterprise Value
2.34BUSDvs all stocks (USD)
Forward P/E
-7.47xvs Diagnostics & Research peers
Price to Sales (TTM)
19.96xvs Diagnostics & Research peers
Price to Book (MRQ)
1.19xvs Diagnostics & Research peers
Enterprise to Revenue
15.02xvs Diagnostics & Research peers
Enterprise to EBITDA
-6.50xvs Diagnostics & Research peers
Gross Margin
-35.08%vs Diagnostics & Research peers
Profit Margin
-253.22%vs Diagnostics & Research peers
Operating Margin
-332.88%vs Diagnostics & Research peers
Return on Assets (TTM)
-11.42%vs Diagnostics & Research peers
Return on Equity (TTM)
-16.09%vs Diagnostics & Research peers
Revenue (TTM)
156.12MUSDvs all stocks (USD)
Revenue per Share (TTM)
4.07USDUpdated Jul 19, 2026Quarterly Revenue Growth
28.10%vs Diagnostics & Research peers
Gross Profit (TTM)
76.94MUSDvs all stocks (USD)
EBITDA (TTM)
-360.50MUSDvs all stocks (USD)
Net Income (TTM)
-395.32MUSDvs all stocks (USD)
Quarterly Earnings Growth (YoY)
28.11%vs Diagnostics & Research peers
Operating Cash Flow (TTM)
-290.98MUSDvs all stocks (USD)
Levered Free Cash Flow (TTM)
-107.75MUSDvs all stocks (USD)
Trailing Annual Dividend Rate
0.00USDUpdated Jul 19, 2026Trailing Annual Dividend Yield
0.00%vs all stocks
Payout Ratio
0.00%vs Diagnostics & Research peers
Revenue
147.17MUSDFY2025 · Dec 31, 2025Cost of Goods Sold
209.75MUSDFY2025 · Dec 31, 2025Gross Profit
-62.57MUSDFY2025 · Dec 31, 2025Operating Income
-534.16MUSDvs all stocks (USD)
Pre-tax Income
-534.50MUSDFY2025 · Dec 31, 2025Income Tax Expense
-126.15MUSDFY2025 · Dec 31, 2025Net Income
-408.35MUSDFY2025 · Dec 31, 2025EBIT
-534.16MUSDFY2025 · Dec 31, 2025EBITDA (Income Statement)
-349.82MUSDFY2025 · Dec 31, 2025Research & Development
195.79MUSDFY2025 · Dec 31, 2025Selling, General & Administrative
275.80MUSDFY2025 · Dec 31, 2025Non-operating Interest Income
28.65MUSDFY2025 · Dec 31, 2025EPS (Basic)
-11.11USDFY2025 · Dec 31, 2025EPS (Diluted)
-11.11USDFY2025 · Dec 31, 2025Basic Shares Outstanding
36.75MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
36.75MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
-408.35MUSDFY2025 · Dec 31, 2025Operating Cash Flow
-315.94MUSDFY2025 · Dec 31, 2025Free Cash Flow
-316.85MUSDFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
256.70MUSDFY2025 · Dec 31, 2025Starting Profit (CF Statement)
-408.35MUSDFY2025 · Dec 31, 2025Depreciation & Amortization
156.34MUSDFY2025 · Dec 31, 2025Deferred Taxes (CF)
-126.15MUSDFY2025 · Dec 31, 2025Stock-based Compensation
58.28MUSDFY2025 · Dec 31, 2025Other Non-cash Items
1.35MUSDFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
1.69MUSDFY2025 · Dec 31, 2025Change in Accounts Payable (CF)
-2.73MUSDFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
3.64MUSDFY2025 · Dec 31, 2025Capital Expenditures
-909.00KUSDFY2025 · Dec 31, 2025Purchase of Investments
-1.31BUSDFY2025 · Dec 31, 2025Sale of Investments
1.22BUSDFY2025 · Dec 31, 2025Net Investing Cash Flow
-85.05MUSDFY2025 · Dec 31, 2025Net Financing Cash Flow
418.80MUSDFY2025 · Dec 31, 2025Shares Outstanding
41.13MSharesUpdated Jul 19, 2026Float Shares
33.47MSharesUpdated Jul 19, 2026Shares Short
7.75MSharesUpdated Jul 19, 2026Short Ratio
9.20daysvs all stocks
Short % of Shares Outstanding
18.37%vs all stocks
% Held by Insiders
5.23%vs all stocks
% Held by Institutions
83.51%vs all stocks
Total Cash (MRQ)
823.11MUSDvs all stocks (USD)
Total Cash per Share (MRQ)
19.18USDUpdated Jul 19, 2026Total Debt (MRQ)
51.03MUSDvs all stocks (USD)
Total Debt to Equity (MRQ)
0.0204xvs Diagnostics & Research peers
Current Ratio (MRQ)
11.74xvs Diagnostics & Research peers
Book Value per Share (MRQ)
60.79USDUpdated Jul 19, 2026Total Assets
2.92BUSDvs all stocks (USD)
Total Current Assets
953.85MUSDFY2025 · Dec 31, 2025Total Liabilities
344.15MUSDFY2025 · Dec 31, 2025Total Non-current Assets
1.97BUSDFY2025 · Dec 31, 2025Total Non-current Liabilities
264.48MUSDFY2025 · Dec 31, 2025Total Current Liabilities
79.67MUSDFY2025 · Dec 31, 2025Cash & Cash Equivalents
249.73MUSDFY2025 · Dec 31, 2025Other Short-term Investments
654.70MUSDFY2025 · Dec 31, 2025Accounts Receivable
18.30MUSDFY2025 · Dec 31, 2025Inventory
16.02MUSDFY2025 · Dec 31, 2025Accounts Payable
2.08MUSDFY2025 · Dec 31, 2025Short-term Debt
11.71MUSDFY2025 · Dec 31, 2025Other Current Liabilities
1.93MUSDFY2025 · Dec 31, 2025Long-term Debt
43.15MUSDFY2025 · Dec 31, 2025Other Non-current Liabilities
2.75MUSDFY2025 · Dec 31, 2025Common Stock (Book)
40.00KUSDFY2025 · Dec 31, 2025Retained Earnings
-10.21BUSDFY2025 · Dec 31, 2025Total Shareholders' Equity
2.58BUSDvs all stocks (USD)
52-Week Low
29.95USDUpdated Jul 19, 202652-Week High
118.84USDUpdated Jul 19, 202652-Week Change
111.41%vs all stocks
Beta
3.22xvs all stocks
50-Day MA
65.38USDUpdated Jul 19, 2026200-Day MA
74.10USDUpdated Jul 19, 2026Avg 10-Day Volume
505.32KSharesUpdated Jul 19, 2026Avg 30-Day Volume
619.47KSharesUpdated Jul 19, 2026Diluted EPS (TTM)
-10.30USDUpdated Jul 19, 2026Other Income / Expense
-28.99MUSDFY2025 · Dec 31, 20252 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsIs this company financially stable?
Low-Leverage Liquidity Configuration
Cash on hand covers most or all of its debt, and its equity share of assets is high for its industry.
Reads
Multi-Year Debt Decrease With Cash Near Total Debt And Equity
Long-term debt down in each of four years, and cash now covers most or all of what is left.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
Gross margin is -35.1%, lower than 95% of its Diagnostics & Research peers (median 47%)Significant
Gross margin: -0.35Industry median: 0.47Industry P5: 0.15Peers compared: 28.00
Operating margin is -332.9%, lower than 95% of its Diagnostics & Research peers (median 9.9%)Significant
Operating margin: -3.33Industry median: 0.10Industry P5: -0.95Peers compared: 28.00
Profit margin is -253.2%, lower than 95% of its Diagnostics & Research peers (median 4.5%)Significant
Profit margin: -2.53Industry median: 0.05Industry P5: -0.83Peers compared: 28.00
Debt-to-equity is 0.02×, lower than 95% of its Diagnostics & Research peers (median 0.3×)Notable
Debt-to-equity: 0.02Industry median: 0.30Industry P5: 0.02Peers compared: 28.00
Price-to-book is 1.19×, lower than 95% of its Diagnostics & Research peers (median 3.52×)Notable
Price-to-book: 1.19Industry median: 3.52Industry P5: 1.51Peers compared: 28.00
Structural Tensions
Looks liquid, but the distress score says otherwiseNotable
Current Ratio: 11.74Altman Z-Score: 0.35
Financial Health
Altman Z-Score 0.35: distress zoneCritical
Altman Z-Score: 0.35
Supply Chain
Midstream position: 6 outgoing, 6 incoming connectionsNotable
Outgoing: 6.00Incoming: 6.00
High connectivity hub: 12 industry connectionsNotable
Total Connections: 12.00
Scale
Market cap is $3.12B, above the global median of $1.15BNotable
Market cap (USD): 3,116,602,983Global Median: 1,146,734,693.424
Companies that share the same coordination system — how they create, deliver, or capture value.
Hayward Holdings Inc.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Shenzhen Zesum Technology Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Ardentec Corporation
Tier 1ProductionThroughput-Bound ConversionRuleFlow
Titan America S.A.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Sichuan Hebang Biotechnology Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
North Industries Group Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleRisk
Wingtech Technology Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionSenseMakingRule
Carl Zeiss Meditec AG
Tier 1ProductionThroughput-Bound ConversionRule
Shanghai Gentech Co. Ltd.
Tier 1ProductionThroughput-Bound ConversionSenseMakingRule
China First Heavy Industries Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionSenseMakingRisk
Companies that share active interpretations — structural patterns currently present in both stocks.
Nanjing Xinjiekou Department Store Co. Ltd.
2 interpretationsMulti-Year Debt Decrease With Cash Near Total Debt And EquityLow-Leverage Liquidity Configuration
Olaplex Holdings, Inc.
2 interpretationsMulti-Year Debt Decrease With Cash Near Total Debt And EquityLow-Leverage Liquidity Configuration
Wuhan Easydiagnosis Biomedicine Co., Ltd.
2 interpretationsMulti-Year Debt Decrease With Cash Near Total Debt And EquityLow-Leverage Liquidity Configuration